Skip to content
Research Article Open access CC BY 4.0

Role of Hypouricemic Agents in Tumor Lysis Syndrome: A Meta-Analysis

Waleed Alshehri, Abdulrahman Aljohani, Reem Alhasani, Anood Alshammari, Jwael A. Alhamoud, Atheer Alruwaili, Omniah Altemani, Ali Bahabri, Hassan Alahmadi, Shaykhah Alderaan, Afnan Almutairi, Marwan Alsehli, Mohammed Almohammadi, Faisal Almaleki, Hamoud Alotaibi

Journal of Pharmaceutical Research International · pp. 183–196 · Published 25 Jun 2021

10.9734/jpri/2021/v33i33A31785

Abstract

Objective and background: Tumor lysis syndrome (TLS) is a life-threatening emergency and demands emergency care of effective outcome with minimal or no side effects. The Hypouricemic agents, including Rasburicase, Allopurinol and Febuxostate used for the management of TLS. This study was designed to evaluate the Role of Hypouricemic agents by analyzing TLS development rate, control of uric acid, and Creatinine levels. Methods: An extensive electronic data search was conducted by using all leading scientific databases. Twenty-six studies were selected to conduct this study, as per the inclusion criteria. Results: The Odd ratio of TLS development rate was 4.06, 1.24, and 1.49 by Rusbricase, Allopurinol & Febuxostate administration respectively. 95% confidence interval was reported by selected studies against TLS development rate, Uric acid, and Creatinine levels by administrating Rusbricase, Allopurinol & Febuxostate. Conclusion: All Hypouricemic agents, including Rasburicase, Allopurinol and Febuxostate, are effective to manage Tumor lysis Syndrome. However, a suitable and most effective intervention dose needs to identify with better efficacy and minimal side effects both in Adults and Children. 

Tumor lysis Syndrome (TLS) hypouricemic agents rusbricase allopurinol febuxostate

Cited by 1

Rasburicase in treating tumor lysis syndrome: An umbrella review

Kamran Mahfooz, Haris Sohail, Ani Gvajaia · Cancer Pathogenesis and Therapy · 2023

Article metrics

Real usage data collected on this platform.

7

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.